Navigation Links
Global HIV Infection Drug Pipeline Analysis
Date:12/13/2013

MUMBAI, December 13, 2013 /PRNewswire/ --

Bharat Book Bureau presents Global HIV Infection Drug Pipeline Analysis. This report provides the discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retroviral in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have been successful in improving the quality of life for HIV patients and prevented the virus from developing into AIDS. The rate of HIV infection and the number of deaths due to AIDS has been on a declining note at a positive rate across the globe. It has been estimated that the death rate reduced from 2.3 million in 2005 to 1.6 in 2012, with the rates for children being even much lower. A major cause for such drastic changes in the infection rates has been the improved access to antiretroviral drugs and therapy in recent years.

     (Logo: http://photos.prnewswire.com/prnh/20130128/590935)

Bharat Book Bureau presents the report entitled "Global HIV Infection Drug Pipeline Analysis" (http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html ) It gives comprehensive insight on the various drugs being developed for the treatment of HIV Infection. Research report covers all the ongoing drugs being developed in various clinical development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the HIV Infection drug market based upon development process.

Following parameters for each drug profile in clinical development phase are covered in "Global HIV Infection Drug Pipeline Analysis" research report:

  • Drug Profile Overview
  • Alternate Names for Drug
  • Active Indication
  • Phase of Development
  • Mechanism of Action
  • Brand Name
  • Patent Information
  • Orphan Designation by Indication, Country & Organization
  • Country for Clinical Trial
  • Owner / Originator/ Licensee/Collaborator
  • Administrative Route
  • Drug Class
  • ATC Codes

HIV Infection Drug Development by Clinical Phase:

  • Research: 31
  • Preclinical: 140
  • Phase-I: 53
  • Phase-I/II: 18
  • Phase-II: 39
  • Phase-III: 7
  • Preregistration: 2
  • Registered: 2
  • Marketed: 34

Table of Contents

  • HIV Infection Drug Market Overview
  • HIV Infection Drug Clinical Development Phase: Research
  • Overview
  • HIV Infection Drug Profiles in Clinical Phases
  • HIV Infection Drug Clinical Development Phase: Preclinical
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-I
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-I/II
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-II
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Phase-III
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Preregistration
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • HIV Infection Drug Clinical Development Phase: Registered
  • Overview
  • HIV Infection Drug Profiles in Clinical Phase
  • Marketed Drugs
  • Overview
  • Marketed Drug Profile

Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=430480

For more information on the report: http://www.bharatbook.com/healthcare-market-research-reports/global-hiv-infection-drug-pipeline-analysis.html

Related Reports:

Related Category:

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:

Poonam
Bharat Book Bureau
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Blog: http://blog.bharatbook.com
E: poonam@bharatbook.com
W: http://www.bharatbook.com

 


'/>"/>
SOURCE Bharat Book Bureau
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Equine Healthcare Market is Expected to Reach USD 24.5 Billion Globally in 2019: Transparency Market Research
2. CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
3. Global Radiation Detection, Monitoring & Safety Market Report 2013-2017
4. Industrial Electronics - Global Trends, Estimates and Forecasts, 2011-2018
5. Wearable Medical Devices Market is Expected to Reach USD 5.8 Billion Globally in 2019: Transparency Market Research
6. Global Laparoscopic Devices Industry
7. Global Gelatin Industry
8. Global Carotenoids Industry
9. Upsher-Smith Debuts Positive Results From Global Phase 3 Study Evaluating USL255 (extended-release topiramate) In Epilepsy Patients With Refractory Partial-Onset Seizures
10. Intravenous Access Devices Market is Expected to Reach USD 46.5 Billion Globally in 2019: Transparency Market Research
11. EEG/EMG/Brain Function Monitoring - Global Strategic Business Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/18/2017)... Pa. and KALAMAZOO, Mich. , Sept. 18, ... , and OptiMed Specialty Pharmacy of ... to offer a strategic hub service that expedites and ... sought-after personal spirometer, Spiro PD 2.0, and wellness management ... spirometer is a medical device used to measure lung ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):